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ORIGINAL ARTICLE
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ABSTRACT
Background: Modulation of the commensal oral microbiota constitutes a promising preven-
tive/therapeutic approach in oral healthcare. The use of prebiotics for maintaining/restoring 
the health-associated homeostasis of the oral microbiota has become an important research 
topic.
Aims: This study hypothesised that in vitro 14-species oral biofilms can be modulated by (in) 
direct stimulation of beneficial/commensal bacteria with new potential prebiotic substrates 
tested at 1 M and 1%(w/v), resulting in more host-compatible biofilms with fewer pathogens, 
decreased virulence and less inflammatory potential.
Methods: Established biofilms were repeatedly rinsed with N-acetyl-D-glucosamine, α- 
D-lactose, D-(+)-trehalose or D-(+)-raffinose at 1 M or 1%(w/v). Biofilm composition, metabolic 
profile, virulence and inflammatory potential were eventually determined.
Results: Repeated rinsing caused a shift towards a more health-associated microbiological 
composition, an altered metabolic profile, often downregulated virulence gene expression 
and decreased the inflammatory potential on oral keratinocytes. At 1 M, the substrates had 
pronounced effects on all biofilm aspects, whereas at 1%(w/v) they had a pronounced effect 
on virulence gene expression and a limited effect on inflammatory potential.
Conclusion: Overall, this study identified four new potential prebiotic substrates that exhibit 
different modulatory effects at two different concentrations that cause in vitro multi-species 
oral biofilms to become more host-compatible.
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The oral cavity shelters a highly organized and 
complex consortium of oral microbial species, char-
acterized by the presence of a dynamic equilibrium 
(‘homeostasis’) between these different species [1–6]. 
There also exists a homeostatic equilibrium between 
the polymicrobial microbiota, the host response, and 
the environment [1–6]. Due to environmental 
changes (e.g. dietary alterations) and/or changes in 
the host response (e.g. immune alterations), this bal-
ance can be disrupted, resulting in oral diseases such 
as caries or periodontitis [7–9]. These oral diseases 
are thus the result of a complex interplay between 
commensal and pathogenic bacteria, the environment 
and the host [10–14]. Therefore, maintaining and/or 
restoring the homeostatic relationship between the 
polymicrobial oral microbiota and host tissues 
might create novel preventive and therapeutic 
options. The development of such new approaches 
is of high importance, considering the emerging issue 
of increased adaptation and resistance development 
of oral bacterial species to antimicrobial agents such 
as antibiotics or antiseptics [15–19].
In an attempt to maintain and/or restore the 
health-associated homeostasis of the resident oral 
microbiota and also modulate the host response, 
mainly pro- and prebiotic approaches gained a lot of 
interest in recent years [8,10,20,21]. The microbiolo-
gical and clinical benefits of probiotics have been 
shown and they are being used in oral healthcare for 
several years now [22,23]. However, although success-
fully used for gastro-intestinal diseases [24], only 
recently an in vitro proof-of-concept for the use of 
prebiotics in oral healthcare was delivered [25,26]. 
The International Scientific Association for 
Probiotics and Prebiotics (ISAPP) recently published 
the most up-to-date definition and scope of prebio-
tics. In this statement, a prebiotic is defined as ‘a 
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substrate that is selectively utilized by host 
microorganisms conferring a health benefit’[27]. 
Therefore, prebiotics represent a whole different 
approach than probiotics, which are defined as ‘live 
microorganisms that are administered in such 
amounts that they eventually provide a health benefit 
for the host’[27]. Several in vitro and in vivo studies 
investigated the effects of potential prebiotic sub-
strates on oral health [25,26,28–30]. For instance, 
Slomka and co-workers screened a wide range of 
compounds on their ability to selectively stimulate 
beneficial oral bacteria which in turn suppressed 
pathogenic oral bacteria in an in vitro dual species 
biofilm [25]. Later on, they found that three of these 
potential prebiotic substrates caused a clear shift in 
the proportion of beneficial/commensal species 
(>95%) in an in vitro, 14-species oral biofilm [26]. 
Furthermore, they also observed that the prebiotic 
effect was influenced by several environmental fac-
tors, such as substrate dose, oxygen concentration 
and nutrient availability [26]. Other studies focused 
on the effects of one particular prebiotic substrate, 
namely arginine, which was found to have beneficial, 
health-associated effects on the composition and 
metabolic activity of both in vitro and in vivo micro-
bial communities from a caries point of view [28–30]. 
All these findings indicate promising potential for the 
use of prebiotics for oral health. However, further 
in vitro and in vivo research is still required before it 
can eventually be applied in humans as a widespread 
preventive or therapeutic strategy.
The main hypothesis of this study was that in vitro 
multi-species oral biofilms can be modulated by (in) 
direct stimulation of beneficial/commensal bacteria 
with certain substrates, resulting in more host- 
compatible biofilms that harbour lower amounts of 
pathogens, show decreased virulence and have less 
inflammatory potential. The aim was to identify 
new potential prebiotic substrates, which (in)directly 
stimulate the beneficial/commensal oral bacteria in 
terms of growth and/or metabolism and/or activities 
and by consequence inhibit pathogenic oral bacteria, 
decrease virulence gene expression and reduce the 
inflammatory response of oral keratinocytes exposed 
to multi-species oral biofilms treated with these 
substrates. The substrates were tested at two concen-
trations: a high concentration of 1 M and a low 
concentration of 1%(w/v) (with mentioning of the 
corresponding molar concentrations). The rationale 
for this was to allow for comparison with the pre-
viously mentioned proof-of-concept study of Slomka 
et al. [26], where the effects of the potential prebiotic 
substrates were most pronounced at concentrations 
around 1 M. Although such a high concentration is 
acceptable for proving concepts at an in vitro level, it 
is difficult to apply in a real-life situation. Therefore, 
the lower 1%(w/v) concentration was evaluated as well, 
as this is a more realistic concentration for 
formulating compounds in commercially available 
mouthwashes or toothpastes.
MATERIAL AND METHODS
Bacterial strains, media and culture conditions
Bacterial species and strains used in this study as 
representative commensal oral bacteria, representa-
tive periodontal pathogens or representative cario-
genic pathogens are listed in Table 1. Culture and 
incubation conditions have been described by Slomka 
and co-workers [26].
Bioreactor-derived multi-species community
A 14-species community was grown in a Biostat 
B Twin 1 L bioreactor (Sartorius Stedim Biotech 
GmbH, Goettingen, Germany) with controlled envir-
onmental conditions as previously described by 
Slomka and co-workers [26].
Substrates
N-acetyl-D-glucosamine, D-(+)-raffinose, D-(+)- 
trehalose (all Sigma-Aldrich Co, St. Louis, USA) and 
α-D-lactose (Acros Organics – Thermo Fisher 
Scientific, Waltham, USA) were selected from of 
a larger high-throughput screening for nutritional 
sources using Phenotype MicroArray (PM) panels 
and were selected because they exhibited (some) 
potential to function as prebiotic substrates [25]. 
Substrates were dissolved in phosphate-buffered sal-
ine (PBS) with pH adjusted to 5.7 using citric acid, 










S. mutans ATCC 
25175
A. viscosus ATCC 
15987
F. nucleatum ATCC 10953 S. sobrinus ATCC 
33478
S. gordonii ATCC 
49818 #
P. gingivalis ATCC 33277
S. mitis DSM 12643 # P. intermedia ATCC 25611
S. oralis DSM 20627 #
S. salivarius TOVE-R
S. sanguinis LMG 
14657 #
V. parvula DSM 2008
# Species that are often considered as beneficial commensals due to their 
production of H2O2, which plays an important role in, for instance, the 
inhibition of other (pathogenic) species and during oral biofilm 
development. 
A. naeslundii: Actinomyces naeslundii, A. viscosus: Actinomyces viscosus, 
S. gordonii: Streptococcus gordonii, S. mitis: Streptococcus mitis, S. oralis: 
Streptococcus oralis, S. salivarius: Streptococcus salivarius, S. sanguinis: 
Streptococcus sanguinis, V. parvula: Veillonella parvula; 
A. actinomycetemcomitans: Aggregatibacter actino-mycetemcomitans, 
F. nucleatum: Fusobacterium nucleatum, P. gingivalis: Porphyromonas 
gingivalis, P. intermedia: Prevotella intermedia, S. mutans: Streptococcus 
mutans, S. sobrinus: Streptococcus sobrinus. 
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followed by filter sterilization. Substrates were tested 
at concentrations of 1 M and 1%(w/v), the latter, 
respectively, corresponding to 45 mM (NADG), 
29 mM (α-D-lactose), 17 mM (D-(+)-raffinose), and 
26 mM (D-(+)-trehalose).
Multi-species biofilm rinsing assays
A sample was taken from the bioreactor vessel, 
diluted 1:10 in fresh modified Brain Heart Infusion 
(BHI) medium [31] and added to a 24-well plate 
(2 mL/well). Biofilms were grown vertically on 
Calcium Deficient Hydroxyapatite (CAD-HA) disks 
(Hitemco Medical, Old Bethpage, USA) using the 
Amsterdam Active Adhesion model [32]. Biofilms 
were allowed to establish during 24 h (37°C, 
170 rpm) under micro-aerophilic conditions (6% 
O2, 7% CO2, 7% H2, 80% N2). After this 24 h, disks 
were rinsed 3 times a day for 3 minutes (RT, 
250 rpm), for 3 consecutive days, by transferring the 
lid containing the disks to a new 24-well plate 
containing 2 mL/well of the appropriate substrate 
solution. As a negative control, PBS (pH 5.7) without 
substrate supplementation was used. Following each 
rinsing step, disks were shortly dip-rinsed in a new 
24-well plate containing 2 mL/well of fresh modified 
BHI medium to remove residual substrate traces. 
Next, the lid was transferred to a new 24-well plate 
containing 2 mL/well of fresh modified BHI medium, 
ultimately followed by re-incubation of the plates (37° 
C, 170 rpm, micro-aerophilic) until the next rinsing 
step. The morning after the final rinsing step on the 
third day, disks were dip-rinsed in PBS (pH 7.4) to 
remove unattached cells, followed by bacterial DNA 
or RNA extraction or by biofilm challenge of human 
cells (see lower). All experiments were repeated on 
three different days.
Bacterial DNA extraction and quantification
Biofilm-coated disks were dip-rinsed in PBS (pH 7.4) 
to remove unattached cells, after which biofilms were 
disrupted, bacterial cells harvested and DNA from 
only living bacteria was extracted, employing 
a propidium monoazide (PMA) treatment, as 
described before [26]. Subsequent quantification of 
bacterial species was done through quantitative PCR 
(qPCR) assay as described previously [26], species- 
specific primers and probes used were identical to 
those listed earlier by Herrero et al. [33].
Organic acid analysis
Concentrations of organic acids in the filter sterilized 
supernatant of the multi-species biofilms were mea-
sured using a 761 Compact Ion Chromatograph 
(Metrohm, Switzerland) with a Metrosep Organic 
acids Guard/4.6 guard column. The eluent consisted 
of 1 mM H2SO4 at a flow rate of 0.8 mL min−1. 
Organic acid production/consumption was calculated 
as the organic acid concentrations detected in the 
filter sterilized biofilm supernatant, minus the con-
centrations of those organic acids detected in sterile 
modified BHI medium.
Bacterial RNA extraction and virulence gene 
expression analysis
Biofilm-coated disks were dip-rinsed in PBS (pH 7.4) 
to remove unattached cells, after which bacterial RNA 
was extracted through a mechanical disruption and 
acid phenol-chloroform extraction as described by 
Vandecasteele et al. [34] in combination with the 
RNeasy Mini Kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s protocol. After quality and 
integrity assessment, a concentration-dependent nor-
malization of all RNA samples was performed, fol-
lowed by conversion of RNA to complementary DNA 
(cDNA) using the PrimeScript 1st strand cDNA 
Synthesis Kit (Takara, Shiga, Japan) according to the 
manufacturer’s instructions. Expression of bacterial 
virulence genes was analysed through SYBR RT- 
qPCR and normalized for bacterial housekeeping 
gene (species-specific 16S rRNA or other genes) 
expression. Each reaction mixture consisted of 
12.5 µL ROX SYBR Master Mix blue dTTP 
(Eurogentec, Seraing, Belgium), 5.5 µL distilled 
water, 1 µL of both forward and reverse species- 
specific primer (final primer concentration of 
400 nM) and 5 µL of template cDNA. Assay condi-
tions consisted of an initial 2 min at 50°C, followed 
by a denaturation step of 10 min at 95°C, 45 cycles of 
15 s at 95°C and 60 s at 60°C. Specific sequences of 
each primer pair can be found elsewhere [35]. Data 
were determined as a function of the threshold cycle 
(CT) values and relative virulence gene expression 
was calculated according to the ΔΔCT method 
(2−(ΔCTexp – ΔCTcontrol)).
Biofilm challenge of cells
Cultures of immortalized human oral keratinocytes 
(HOK-18A) were grown as described previously [36]. 
Sterile silicone rings (Peleman BVBA, Wilsele, 
Belgium) were placed at the bottom of 24-well plates 
after which the HOK-18A cultures were seeded and 
grown until confluence. Biofilm-coated disks were 
dip-rinsed in PBS (pH 7.4) to remove unattached 
cells and set on the silicone rings with the biofilm 
facing the cell monolayer. The presence of the ring 
ensured a fixed distance of 1 mm between biofilm 
and cell monolayer. Following 2 h of contact (37°C, 
5% CO2, 170 rpm), rings and disks were removed, 
cells were washed twice with PBS (pH 7.4) and fresh 
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cell culture medium containing 0.1 mg/mL gentamy-
cin was added, followed by incubation (37°C, 5% 
CO2, 170 rpm) for 2 h. Next, cells were harvested 
and cellular RNA was extracted with the RNeasy kit 
(Qiagen, Hilden, Germany) according to the manu-
facturer’s instructions. RNA was converted to cDNA 
and relative expression of inflammatory mediator 
genes was determined as described above with respect 
to the cellular housekeeping gene β-actin. In addition, 
cell culture supernatants were collected and analysed 
by means of enzyme-linked immunosorbent assay 
(ELISA) to detect CXCL8 (interleukin-8) using the 
Human IL-8 ELISA Kit (Thermo Fisher Scientific, 
Waltham, USA) according to the manufacturer’s pro-
tocol. All experiments were repeated on three differ-
ent days.
Statistical analysis
GraphPad Prism version 7.04 for Windows 
(GraphPad Software, La Jolla, California, USA) was 
used for statistical analysis. For all experiments, com-
parisons with the control were set up and analysed 
through a one-way ANOVA with a confidence level 
of 95% and a correction for simultaneous hypothesis 
testing was applied according to Dunnett to detect 
statistically significant differences (P < 0.05). 
Normality of the residuals was assessed by means of 
a Shapiro–Wilk test and a normal quantile plot.
DATA AVAILABILITY
The authors declare that all data supporting the 
findings of this study are available within the paper 
and its supplementary information files.
RESULTS
Effects of substrates on multi-species biofilm 
composition
N-acetyl-D-glucosamine (NADG), α-D-lactose, 
D-(+)-trehalose and D-(+)-raffinose were selected to 
determine their effects on multi-species biofilm com-
position. Repeated rinsing of the biofilms with the 
substrates at a concentration of 1 M resulted in a sig-
nificant decrease in absolute numbers of all four 
periodontal pathogens compared to the control 
(Figure 1a, Supplementary Table S1). These 
decreases (expressed as logarithmic value of the 
amount of genome equivalents per millilitre; log 
(Geq/mL)) were approximately ~1–1.4 log(Geq/mL)
Figure 1. Effects of repeated rinsing with potential prebiotic substrates at 1 M on multi-species biofilm composition.
Panel a: Absolute abundances of pathogenic oral species (periodontal and cariogenic pathogens) (upper graph) and beneficial/commensal oral 
species (lower graph) are shown as mean ± SD (n = 3) logarithmic values of the genome equivalents per millilitre (log(Geq/mL)). Panel b: 
Relative abundances of the different groups (beneficial/commensals, periodontal pathogens, cariogenic pathogens) of bacterial species are 
shown as mean ± SD (n = 3) percentage of the genome equivalents per millilitre (%(Geq/mL)). All substrates were dissolved in PBS at 
a concentration of 1 M. Statistically significantly different values when compared to the control (PBS) are marked with ‘*’ (P < 0.05, ANOVA + 
Dunnett’s correction for simultaneous hypothesis testing). Aa: A. actinomycetemcomitans; Fn: F. nucleatum; Pg: P. gingivalis; Pi: P. intermedia; An: 
A. naeslundii; Av: A. viscosus; S. gord.: S. gordonii; S. sal.: S. salivarius; S. sang.: S. sanguinis; Vp: V. parvula; NADG: N-acetyl-D-glucosamine.
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for A. actinomycetemcomitans, ~2.3–4 log(Geq/mL) for 
F. nucleatum, ~2.4–2.7 log(Geq/mL) for P. gingivalis 
and ~2–3.2 log(Geq/mL) for P. intermedia. The num-
bers of the cariogenic pathogens S. mutans and 
S. sobrinus were usually increased with ~0.6–1.3 log 
(Geq/mL) compared to the control, with statistical sig-
nificance being reached for S. mutans in the case of 
D-(+)-trehalose and D-(+)-raffinose, and for S. sobrinus 
in the case of α-D-lactose and D-(+)-trehalose. 
Interestingly, NADG resulted in a significant decrease 
in S. sobrinus numbers with ~3 log(Geq/mL). The 
numbers of the commensal species A. naeslundii (for 
all substrates) and A. viscosus (for D-(+)-trehalose) were 
often significantly decreased with ~1.9–2.5 log(Geq/ 
mL), and V. parvula showed significant reductions of 
~0.7 log(Geq/mL) for α-D-lactose and D-(+)-trehalose 
(Figure 1a, Supplementary Table S1). When consider-
ing the beneficial/commensal streptococcal species, the 
bacterial numbers generally increased with ~0.2–1.3 log 
(Geq/mL), except for S. sanguinis, with statistical sig-
nificance being reached for S. gordonii (NADG), 
S. oralis (D-(+)-raffinose) and S. salivarius (all four 
substrates) (Figure 1a, Supplementary Table S1).
In terms of relative proportions (%(Geq/mL)) 
(Figure 1b), the control treatment resulted in 
a biofilm consisting of 74.21 ± 6.47% beneficial/ 
commensal species, 25.67 ± 6.52% periodontal patho-
gens and 0.13 ± 0.06% cariogenic pathogens. Rinsing 
with the substrates resulted in significantly lower 
proportions of periodontal pathogens (1.46 ± 0.97%, 
1.46 ± 0.64%, 1.80 ± 1.04% and 2.29 ± 1.40% for 
NADG, α-D-lactose, D-(+)-trehalose and D-(+)- 
raffinose, respectively) when compared to the control 
condition. All substrates also resulted in significantly 
higher proportions of beneficial/commensal species 
(97.86 ± 1.11%, 92.72 ± 4.39%, 88.98 ± 9.12% and 
95.86 ± 1.63% for NADG, α-D-lactose, D-(+)- 
trehalose and D-(+)-raffinose, respectively). 
Proportions of cariogenic pathogens were elevated in 
all cases (0.68 ± 0.33%, 5.82 ± 3.94%, 9.22 ± 8.55% and 
1.85 ± 0.68% for NADG, α-D-lactose, D-(+)-trehalose 
and D-(+)-raffinose, respectively), although never 
significantly when compared to the control.
When rinsing the biofilms with the substrates at 
a concentration of 1%(w/v), absolute numbers of ben-
eficial/commensal species, periodontal pathogens and 
cariogenic pathogens were in general only slightly 
affected compared to the control (changes of ~0-0.6 
log(Geq/mL), without reaching statistical significance 
(Figure 2a, Supplementary Table S2). Only in the
Figure 2. Effects of repeated rinsing with potential prebiotic substrates at 1%(w/v) on multi-species biofilm composition.
Panel a: Absolute abundances of pathogenic oral species (periodontal and cariogenic pathogens) (upper graph) and beneficial/commensal 
oral species (lower graph) are shown as mean ± SD (n = 3) logarithmic values of the genome equivalents per millilitre (log(Geq/mL)). Panel b: 
Relative abundances of the different groups (beneficial/commensals, periodontal pathogens, cariogenic pathogens) of bacterial species are 
shown as mean ± SD (n = 3) percentage of the genome equivalents per millilitre (%(Geq/mL)). All substrates were dissolved in PBS at 
a concentration of 1%(w/v) (corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM 
(D-(+)-trehalose)). Statistically significantly different values when compared to the control (PBS) are marked with ‘*’ (P < 0.05, ANOVA + 
Dunnett’s correction for simultaneous hypothesis testing). Aa: A. actinomycetemcomitans; Fn: F. nucleatum; Pg: P. gingivalis; Pi: P. intermedia; An: 
A. naeslundii; Av: A. viscosus; S. gord.: S. gordonii; S. sal.: S. salivarius; S. sang.: S. sanguinis; Vp: V. parvula; LOD: limit of detection (=2.65 log(Geq/ 
mL)); NADG: N-acetyl-D-glucosamine.
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case of S. oralis, a significant decrease of ~0.9 log 
(Geq/mL) could be observed for D-(+)-raffinose. 
Tendencies for higher proportions of beneficial/ 
commensal species and lower proportions of period-
ontal pathogens were observed, but significant 
differences compared to the control condition were 
never reached. The proportions of cariogenic pathogens 
were usually unchanged, except for those in the NADG 
condition, which resulted in a significantly higher pro-
portion of cariogenic species (0.66 ± 0.27%) compared 
to the control (0.16 ± 0.06%) (Figure 2b).
Effects of substrates on multi-species biofilm 
organic acid balances
The supernatants from the substrate-treated multi- 
species biofilms were analysed to gain more insight 
into the influence of the substrates on organic acid 
metabolism. For substrate concentrations of 1 M 
(Figure 3a, Supplementary Table S3), a significantly 
increased lactate production was observed in the case 
of α-D-lactose (3791 ± 169 mg/L), D-(+)-trehalose 
(4187 ± 200 mg/L) and D-(+)-raffinose (971 ± 
43 mg/L) compared to the control condition (con-
sumption of 125 ± 0 mg/L). Formate production was 
significantly lower for α-D-lactose and D-(+)- 
trehalose in comparison with the control condition 
(84 ± 9 mg/L and 75 ± 8 mg/L vs. 384 ± 19 mg/L). α- 
D-lactose (881 ± 73 mg/L), D-(+)-trehalose (1021 ± 
73 mg/L) and D-(+)-raffinose (2640 ± 154 mg/L) all 
resulted in significantly lower acetate production 
compared to the control condition (3779 ± 305 mg/ 
L). NADG, α-D-lactose, D-(+)-trehalose and D-(+)- 
raffinose all resulted in a significantly different 
production of propionate (2750 ± 40 mg/L, 
1306 ± 175 mg/L, 1577 ± 46 mg/L and
Figure 3. Effects of repeated rinsing with potential prebiotic substrates on multi-species biofilm organic acid balances.
Organic acid levels detected in the supernatants of substrate-treated multi-species biofilms are shown as mean ± SD (n = 3) values (mg/L). 
Values >0 mg/L represent net organic acid production, values <0 mg/L represent net organic acid consumption. Substrates were dissolved in 
PBS at a concentration of 1 M (panel a) or 1%(w/v) (panel b) (corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM 
(D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Statistically significantly different values when compared to the control (PBS) are marked with 
‘*’ (P < 0.05, ANOVA + Dunnett’s correction for simultaneous hypothesis testing). OA: organic acid; NADG: N-acetyl-D-glucosamine.
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4178 ± 105 mg/L, respectively) and butyrate 
(1255 ± 51 mg/L, 0 ± 0 mg/L, 0 ± 0 mg/L and 
154 ± 26 mg/L, respectively) in comparison with the 
control condition (2094 ± 132 mg/L propionate and 
1870 ± 93 mg/L butyrate).
Rinsing with substrates at concentrations of 
1%(w/v) did not result in significant differences in 
organic acid production/consumption compared to 
the control (Figure 3b, Supplementary Table S3).
Effects of substrates on multi-species biofilm 
virulence gene expression
The virulence of the substrate-treated multi-species 
biofilms was evaluated by analysing the relative 
expression of 33 virulence genes from 4 periodontal 
pathogens. A more detailed overview of these viru-
lence genes and the associated functions of the viru-
lence factors they encode can be found in 
Supplementary Table S4. Significantly different 
gene expressions in the substrate-treated biofilms 
relative to the control biofilms were considered to 
be biologically relevant if their value was more than 
1.5-fold upregulated or more than 2-fold downregu-
lated. Only these results were considered.
In multi-species biofilms rinsed with the substrates 
at concentrations of 1 M, A. actinomycetemcomitans 
and P. gingivalis virulence gene expressions were 
significantly downregulated relative to the control 
condition for most substrates (Table 2,3). In the 
case of A. actinomycetemcomitans, these downregula-
tions ranged from 2-fold up to 100-fold (NADG), 
2.4-fold to 100-fold (α-D-lactose), 2.5-fold to 100- 
fold (D-(+)-trehalose) and 5.9-fold to 100-fold 
(D-(+)-raffinose). Noteworthy was the significantly 
upregulated expression of pgA (11.6-fold for NADG, 
4.3-fold for α-D-lactose, 18.2-fold for D-(+)-trehalose 
and 7.3-fold for D-(+)-raffinose). For P. gingivalis, 
downregulations ranged from 2.6-fold to 14-fold 
(NADG), 17-fold to 100-fold (α-D-lactose), 7.7-fold 
up to undetectable (D-(+)-trehalose) and 33-fold to 
100-fold (D-(+)-raffinose). In contrast, F. nucleatum 
virulence gene expression was in general significantly 
upregulated (2.5- to 250-fold) by all substrates rela-
tive to the control (Table 4). However, the upregula-
tion induced by NADG was more limited and only 
significant for 2 genes, encoding the ABC transporter 
permease and the hemin receptor (3.3-fold in both 
cases). For P. intermedia, a more diverse impact of 
the substrates on virulence gene expression was 
observed (Table 5). α-D-lactose primarily signifi-
cantly downregulated the expression of virulence 
genes (2.1- to 8.3-fold), whereas NADG (2.3- to 
20.3-fold upregulation), D-(+)-trehalose (7- to 
11.5-fold upregulation and 5-fold downregulation) 
and D-(+)-raffinose (1.9- to 10.6-fold upregulation




 flp 2.40 (0.67-8.67) 0.44 (0.10-1.94) 0.71 (0.30-1.67) 0.45 (0.17-1.22) 
 aae 0.24 (0.18-0.33)* 0.03 (0.01-0.22)* 0.03 (0.01-0.15)* 0.16 (0.05-0.47)* 
 apaH 0.08 (0.02-0.29)* 0.04 (0.01-0.21)* 0.16 (0.04-0.56)* 0.11 (0.02-0.73)* 
 cdtB 0.04 (0.01-0.20)* 0.02 (0.00-0.21)* 0.08 (0.03-0.21)* 0.07 (0.02-0.25)* 
 emaA 0.29 (0.07-1.20)* 0.08 (0.06-0.11)* 0.11 (0.04-0.32)* 0.09 (0.03-0.29)* 
 ltxA 0.01 (0.00-0.20)* 0.01 (0.00-0.08)* 0.01 (0.00-0.01)* 0.01 (0.01-0.03)* 
 omp100 0.03 (0.01-0.05)* 0.08 (0.04-0.15)* 0.09 (0.01-1.11)* 0.09 (0.02-0.43)* 
 omp29 0.19 (0.09-0.38)* 0.42 (0.33-0.52)* 0.74 (0.18-3.00) 1.37 (0.34-5.47) 
 orf859 0.13 (0.05-0.36)* 0.05 (0.00-0.79)* 0.14 (0.02-0.87)* 0.02 (0.01-0.05)* 
 pgA 11.6 (3.23-41.74)* 4.30 (2.21-8.37)* 18.24 (5.89-56.51)* 7.26 (2.09-25.17)* 
 vapA 1.00 (0.58-1.75) 0.22 (0.13-0.36)* 0.32 (0.08-1.26)* 0.50 (0.13-1.94) 
 vppA 0.49 (0.41-0.59) 0.17 (0.06-0.43)* 0.32 (0.01-4.50)* 0.05 (0.04-2.42)* 
1%(w/v) Genes esoniffar-Desolahert-Desotcal-DGDAN
 flp 0.54 (0.19-1.56) 0.81 (0.08-7.83) 0.48 (0.07-3.50) 0.89 (0.40-1.99) 
 aae 1.55 (1.18-2.03) 1.36 (0.70-2.67) 0.95 (0.33-2.78) 1.34 (0.38-4.68) 
 apaH 0.73 (0.41-1.29) 0.84 (0.29-2.49) 0.64 (0.37-1.10) 0.91 (0.48-1.73) 
 cdtB 1.05 (0.61-1.81) 0.66 (0.21-2.03) 0.67 (0.51-0.89) 0.73 (0.16-3.39) 
 emaA 0.68 (0.15-3.07) 0.34 (0.25-0.45)* 0.67 (0.49-0.90) 0.59 (0.13-2.77) 
 ltxA 0.4 (0.11-1.39) 0.04 (0.02-0.08)* 0.08 (0.01-0.73)* 0.30 (0.12-0.79) 
 omp100 0.71 (0.42-1.18) 0.34 (0.23-0.49)* 0.43 (0.26-0.72)* 0.31 (0.09-1.08)* 
 omp29 0.77 (0.69-0.87) 0.81 (0.73-0.89) 0.51 (0.19-1.34)* 0.87 (0.26-2.87) 
 orf859 1.99 (0.94-4.22)* 0.97 (0.37-2.54) 1.04 (0.53-2.03) 1.66 (0.86-3.20) 
 pgA 1.07 (0.29-3.97) 0.55 (0.41-0.74) 0.91 (0.81-1.03) 0.99 (0.38-2.55) 
 vapA 0.65 (0.48-0.86) 0.90 (0.60-1.35) 1.02 (0.87-1.21) 1.14 (0.40-3.20) 
 vppA 0.28 (0.09-0.86)* 0.40 (0.14-1.15)* 0.48 (0.42-0.55)* 1.08 (0.53-2.18) 
relative fold change values
<0.1 0.1-0.3 0.3-0.5 0.5-0.7 0.7-0.9 0.9-1.1 1.1-1.4 1.4-2.0 2.0-3.3 3.3-10.0 >10.0 
Fold changes in virulence gene expression were determined relative to the control condition through the 2−ΔΔCt method and are shown as the 
geometric mean (C.I.) (n = 3) of the 2−ΔΔCt values. All substrates were dissolved in PBS at a concentration of 1 M (upper part) or 1%(w/v) (lower part) 
(corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Values between 0 
and 1 represent relative downregulation, values >1 represent relative upregulation. Statistically, significantly different fold changes relative to the 
control (PBS) that are <0.5 (more than 2-fold downregulated) or >1.5 (more than 1.5-fold upregulated) are considered biologically relevant and are 
shown in bold and marked with ‘*’ (P < 0.05, ANOVA + Dunnett’s correction for simultaneous hypothesis testing). The color code represents the 
magnitude of the fold change in virulence gene expression relative to the control. NADG: N-acetyl-D-glucosamine; C.I.: 95% confidence interval. 
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and 3-fold downregulation) significantly up- or 
downregulated them.
In multi-species biofilms rinsed with the substrates 
at concentrations of 1%(w/v), there was generally 
a significantly decreased A. actinomycetemcomtans 
virulence gene expression (2.3- to 25-fold) (Table 2). 
Only for the NADG condition, the expression of one 
gene (orf859) was significantly upregulated (2-fold). 
The substrates had limited impact on P. gingivalis 
virulence gene expression, with only D-(+)-trehalose 
and NADG having a significant impact on 
respectively kgp (3.2-fold up-regulation) and partC 
(2.8-fold downregulation) expression (Table 3). For 
F. nucleatum, and in contrast with the results 
obtained for substrate concentrations of 1 M, signifi-
cantly decreased virulence gene expression (2- to 10- 
fold) was observed for most of the substrates (Table 
4). For P. intermedia, D-(+)-trehalose and D-(+)- 
raffinose only had a limited impact on virulence 
gene expression, whereas NADG and α-D-lactose in 
general significantly downregulated virulence gene 
expression (2.1- to 3.8-fold) (Table 5).
Table 4. Effects of repeated rinsing of multi-species biofilms with potential prebiotic substrates on virulence gene expression 
from F. nucleatum.
noisserpxeenegecnelurivniegnahcdlofevitaler
1 M Genes NADG D-lactose D-trehalose D-raffinose
 but.-coA transf. 1.21 (0.99-1.49) 3.88 (0.87-17.43)* 4.28 (1.32-13.86)* 3.95 (0.89-17.60)*
 ompA 1.33 (0.78-2.25) 1.26 (0.79-2.03) 1.23 (0.98-1.53) 1.07 (0.49-2.36)
 EF-G 1.45 (0.93-2.26) 1.54 (0.94-2.53) 1.18 (0.46-3.02) 1.41 (0.70-2.83)
 ABC transp. perm. 3.33 (2.53-4.39)* 16.97 (5.93-48.61)* 32.18 (21.08-49.14)* 41.25 (11.65-146.10)* 
 transposase 1.27 (0.68-2.37) 172.87 (147.10-203.20)* 106.44 (42.35-267.50)* 251.47 (75.27-840.20)* 
 hemolysin 1.90 (1.29-2.79) 6.34 (1.36-29.47)* 12.15 (7.73-19.10)* 2.50 (1.07-5.83)* 
 hemin receptor 3.26 (2.24-4.76)* 36.87 (17.27-78.74)* 41.19 (20.31-83.52)* 18.04 (7.92-41.14)* 
1%(w/v) Genes NADG D-lactose D-trehalose D-raffinose
 but.-coA transf. 0.21 (0.11-0.39)* 0.57 (0.40-0.83) 0.40 (0.05-3.27) 0.47 (0.06-3.98) 
 ompA 0.74 (0.18-2.98) 1.13 (0.58-2.19) 0.84 (0.21-3.35) 0.70 (0.20-2.44) 
 EF-G 0.10 (0.02-0.45)* 0.13 (0.03-0.51)* 0.12 (0.03-0.55)* 0.12 (0.04-0.33)*
 ABC transp. perm. 0.33 (0.12-0.87)* 0.25 (0.08-0.78)* 0.40 (0.15-1.03)* 0.17 (0.04-0.65)*
 transposase 0.98 (0.18-5.39) 1.26 (0.51-3.13) 1.02 (0.33-3.12) 0.78 (0.40-1.53) 
 hemolysin 0.79 (0.30-2.04) 1.00 (0.60-1.68) 0.65 (0.15-2.70) 0.51 (0.16-1.62)* 
 hemin receptor 0.19 (0.02-1.67)* 0.17 (0.03-0.94)* 0.16 (0.05-0.50)* 0.12 (0.09-0.15)* 
relative fold change values 
<0.1 0.1-0.3 0.3-0.5 0.5-0.7 0.7-0.9 0.9-1.1 1.1-1.4 1.4-2.0 2.0-3.3 3.3-10.0 >10.0 
Fold changes in virulence gene expression were determined relative to the control condition through the 2−ΔΔCt method and are shown as the 
geometric mean (C.I.) (n = 3) of the 2−ΔΔCt values. All substrates were dissolved in PBS at a concentration of 1 M (upper part) or 1%(w/v) (lower part) 
(corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Values between 0 
and 1 represent relative downregulation, values >1 represent relative upregulation. Statistically significantly different fold changes relative to the 
control (PBS) that are <0.5 (more than 2-fold downregulated) or >1.5 (more than 1.5-fold upregulated) are considered biologically relevant and are 
shown in bold and marked with ‘*’ (P < 0.05, ANOVA + Dunnett’s correction for simultaneous hypothesis testing). The color code represents the 
magnitude of the fold change in virulence gene expression relative to the control. NADG: N-acetyl-D-glucosamine; C.I.: 95% confidence interval; but.- 
coA transf.: butyrate-acetoacetate CoA-transferase; ABC transp. perm.: ABC transporter permease. 
Table 3. Effects of repeated rinsing of multi-species biofilms with potential prebiotic substrates on virulence gene expression 
from P. gingivalis.
noisserpxeenegecnelurivniegnahcdlofevitaler
1 M Genes NADG D-lactose D-trehalose D-raffinose
 kgp 0.07 (0.04-0.13)* <0.01* <0.01* <0.01* 
 fimA 0.79 (0.44-1.39) 0.06 (0.00-1.08)* 0.13 (0.02-0.96)* 0.03 (0.00-0.16)* 
 partC 0.19 (0.13-0.28)* 0.03 (0.01-0.17)* 0.03 (0.00-0.49)* 0.02 (0.00-0.12)* 
 rgpA 0.39 (0.18-0.84) 0.01 (0.00-4.60)* 0.00 (0.00-0.02)* 0.01 (0.00-0.10)* 
1%(w/v) Genes NADG D-lactose D-trehalose D-raffinose
 kgp 1.81 (0.44-7.50) 1.95 (0.45-8.59) 3.24 (1.63-6.44)* 1.77 (0.74-4.21) 
 fimA 1.15 (0.32-4.06) 1.48 (0.27-8.02) 1.58 (0.86-2.90) 1.47 (0.92-2.34) 
 partC 0.36 (0.08-1.68)* 0.47 (0.07-3.04) 0.71 (0.37-1.35) 0.54 (0.26-1.12) 
 rgpA 1.31 (1.03-1.66) 1.49 (0.70-3.20) 1.49 (0.69-3.22) 1.42 (1.12-1.80) 
relative fold change values
<0.1 0.1-0.3 0.3-0.5 0.5-0.7 0.7-0.9 0.9-1.1 1.1-1.4 1.4-2.0 2.0-3.3 3.3-10.0 >10.0
Fold changes in virulence gene expression were determined relative to the control condition through the 2−ΔΔCt method and are shown as the 
geometric mean (C.I.) (n = 3) of the 2−ΔΔCt values. All substrates were dissolved in PBS at a concentration of 1 M (upper part) or 1%(w/v) (lower part) 
(corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Values between 0 
and 1 represent relative downregulation, values >1 represent relative upregulation. Statistically, significantly different fold changes relative to the 
control (PBS) that are <0.5 (more than 2-fold downregulated) or >1.5 (more than 1.5-fold upregulated) are considered biologically relevant and are 
shown in bold and marked with ‘*’ (P < 0.05, ANOVA + Dunnett’s correction for simultaneous hypothesis testing). The color code represents the 
magnitude of the fold change in virulence gene expression relative to the control. NADG: N-acetyl-D-glucosamine; C.I.: 95% confidence interval. 
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Effects of substrates on multi-species biofilm 
inflammatory potential
The relative inflammatory potential of the substrate- 
treated multi-species biofilms was evaluated by analys-
ing the expression of five inflammatory mediator genes 
in human oral keratinocytes (HOKs) exposed to the 
substrate-treated biofilms. Significantly different gene 
expressions in HOKs exposed the substrate-treated bio-
films relative to HOKs exposed to the control biofilms 
were considered to be biologically relevant if their value 
was more than 1.5-fold upregulated or more than 2-fold 
downregulated. Only these results were considered. The 
IL-8 levels in the cellular supernatant were determined 
as well.
In HOKs exposed to substrate-treated (substrate 
concentrations of 1 M) multi-species biofilms, mostly 
decreases in inflammatory mediator gene expression 
were observed (Table 6). IL-8 gene expression was
Table 5. Effects of repeated rinsing of multi-species biofilms with potential prebiotic substrates on virulence gene expression 
from P. intermedia.
noisserpxe eneg ecneluriv ni egnahc dlof evitaler  
 esoniffar-D esolahert-D esotcal-D GDAN seneG M 1
 adpc 2.65 (1.25-5.62)* 0.30 (0.23-0.39)* 1.45 (0.76-2.77) 1.02 (0.40-2.60) 
 clpB 2.03 (0.94-4.41) 0.38 (0.08-1.75)* 1.90 (0.77-4.68) 2.21 (1.53-3.21) 
 dnaK 2.34 (1.23-4.43)* 0.34 (0.28-0.42)* 8.82 (6.83-11.38)* 10.07 (6.81-14.89)* 
 dnaJ 0.64 (0.35-1.16) 0.25 (0.05-1.25)* 1.81 (1.21-2.71) 1.76 (0.92-3.37) 
 ECF 20.32 (4.81-85.88)* 1.72 (0.56-5.25) 6.97 (1.65-29.40)* 6.74 (1.96-23.20)* 
 groES 1.86 (1.38-2.50) 0.29 (0.09-0.91)* 11.52 (2.46-53.90)* 10.59 (4.96-22.60)* 
 htpG 3.40 (2.27-5.08)* 0.19 (0.12-0.31)* 0.67 (0.43-1.03) 1.90 (0.99-3.67)* 
 kpsD 1.72 (0.62-4.72) 0.62 (0.21-1.87) 0.59 (0.47-0.75) 1.78 (0.71-4.45) 
 inpA 4.52 (4.14-4.94)* 0.47 (0.27-0.82)* 0.81 (0.41-1.63) 1.39 (0.67-2.90) 
 phg 0.57 (0.38-0.85)* 0.12 (0.08-0.18)* 0.20 (0.14-0.29)* 0.33 (0.21-0.50)* 
  
1%(w/v) Genes  esoniffar-D esolahert-D esotcal-D GDAN
 adpc 0.67 (0.64-0.69) 0.41 (0.30-0.55) 0.64 (0.29-1.4) 0.83 (0.46-1.51) 
 clpB 1.06 (0.58-1.96) 0.85 (0.23-3.13) 1.30 (0.44-3.83) 1.13 (0.86-1.48) 
 dnaK 0.77 (0.34-1.77) 1.16 (0.55-2.44) 0.78 (0.44-1.36) 1.76 (0.61-5.06) 
 dnaJ 0.70 (0.50-0.99) 0.29 (0.18-0.47)* 0.62 (0.08-4.67) 1.56 (0.59-4.12) 
 ECF 0.48 (0.11-2.02) 0.26 (0.12-0.58)* 0.69 (0.53-0.91) 0.96 (0.56-1.64) 
 groES 0.75 (0.49-1.14) 0.91 (0.41-2.03) 1.22 (0.61-2.45) 0.98 (0.24-4.05) 
 htpG 0.46 (0.22-0.94)* 0.40 (0.15-1.07)* 0.69 (0.42-1.12) 0.67 (0.43-1.04) 
 kpsD 0.78 (0.37-1.62) 0.72 (0.39-1.35) 1.26 (0.52-3.08) 0.90 (0.58-1.40) 
 inpA 0.53 (0.24-1.17)* 0.52 (0.41-0.66)* 0.56 (0.31-1.01)* 0.98 (0.64-1.52) 
 phg 0.69 (0.47-1.00) 0.39 (0.19-0.77)* 0.86 (0.82-0.89) 0.73 (0.33-1.63) 
      
 relative fold change values 
<0.1 0.1-0.3 0.3-0.5 0.5-0.7 0.7-0.9 0.9-1.1 1.1-1.4 1.4-2.0 2.0-3.3 3.3-10.0 >10.0 
Fold changes in virulence gene expression were determined relative to the control condition through the 2−ΔΔCt method and are shown as the 
geometric mean (C.I.) (n = 3) of the 2−ΔΔCt values. All substrates were dissolved in PBS at a concentration of 1 M (upper part) or 1%(w/v) (lower part) 
(corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Values between 0 
and 1 represent relative downregulation, values >1 represent relative upregulation. Statistically significantly different fold changes relative to the 
control (PBS) that are <0.5 (more than 2-fold downregulated) or >1.5 (more than 1.5-fold upregulated) are considered biologically relevant and are 
shown in bold and marked with ‘*’ (P < 0.05, ANOVA + Dunnett’s correction for simultaneous hypothesis testing). The color code represents the 
magnitude of the fold change in virulence gene expression relative to the control. NADG: N-acetyl-D-glucosamine; C.I.: 95% confidence interval. 
Table 6. Effects of repeated rinsing with potential prebiotic substrates on multi-species biofilm inflammatory potential towards 
human oral keratinocytes.
relative fold change in inflammatory mediator gene expression 
1 M Genes NADG  D-lactose  D-trehalose  D-raffinose  
 IL-1β 0.75 (0.55-1.02) 0.50 (0.38-0.65)* 0.79 (0.45-1.38) 0.80 (0.44-1.46) 
 IL-6 0.57 (0.46-0.71) 0.33 (0.12-0.88)* 1.27 (0.11-14.86) 0.54 (0.17-1.72) 
 IL-8 0.14 (0.06-0.36)* 0.03 (0.02-0.05)* 0.22 (0.15-0.34)* 0.10 (0.04-0.29)* 
 MMP-8 1.28 (0.79-2.08) 0.78 (0.38-1.61) 0.81 (0.68-0.95) 0.85 (0.61-1.19) 
 TNF-α 0.89 (0.59-1.34) 0.39 (0.23-0.66)* 0.66 (0.41-1.06)* 0.66 (0.56-0.78)* 
  
1%(w/v) Genes NADG  D-lactose  D-trehalose  D-raffinose  
 IL-1β 0.71 (0.38-1.33)* 0.89 (0.54-1.45) 1.06 (0.55-2.06) 0.93 (0.56-1.55) 
 IL-6 0.73 (0.58-0.93)* 0.74 (0.56-0.97)* 1.00 (0.46-2.17) 0.70 (0.44-1.13)* 
 IL-8 1.00 (0.78-1.27) 1.13 (0.71-1.80) 1.32 (0.89-1.94)* 1.08 (0.73-1.59) 
 MMP-8 0.52 (0.17-1.6)* 0.70 (0.62-0.79) 0.66 (0.46-0.93) 0.71 (0.38-1.35) 
 TNF-α 0.71 (0.28-1.35)* 0.81 (0.50-1.33) 0.94 (0.54-1.64) 0.77 (0.55-1.08) 
      
 relative fold change values 
<0.1 0.1-0.3 0.3-0.5 0.5-0.7 0.7-0.9 0.9-1.1 1.1-1.4 1.4-2.0 2.0-3.3 3.3-10.0 >10.0 
Fold changes in inflammatory mediator gene expression from human oral keratinocytes (HOK-18A) exposed to substrate-treated multi-species biofilms 
were determined relatively to the control through the 2−ΔΔCt method and are shown as the geometric mean (C.I.) (n = 3) of the 2−ΔΔCt values. All 
substrates were dissolved in PBS at a concentration of 1 M (upper part) or 1%(w/v) (lower part) (corresponding molar concentrations: 45 mM (NADG), 
29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Values between 0 and 1 represent relative downregulation, values >1 
represent relative upregulation. Statistically significantly different fold changes relatively to the control (PBS) that are <0.5 (more than 2-fold 
downregulated) or >1.5 (more than 1.5-fold upregulated) are considered biologically relevant and are shown in bold and marked with ‘*’ (P < 0.05). 
The color code represents the magnitude of the fold change in virulence gene expression relatively to the control. NADG: N-acetyl-D-glucosamine; C.I.: 
95% confidence interval. 
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significantly downregulated for all substrates (4.5-fold 
to 33.3-fold). TNF-α gene expression was signifi-
cantly downregulated for the α-D-lactose condition 
(2.5-fold) and this was also the case for IL-1β gene 
expression (2-fold) and IL-6 gene expression (3-fold). 
Absolute IL-8 levels were significantly reduced for all 
substrate conditions (8.4-fold to undetectable) 
(Figure 4a, Supplementary Table S5).
In HOKs exposed to substrate-treated (substrate 
concentrations of 1%(w/v)) multi-species biofilms, the 
relative expression of most inflammatory mediator 
genes was generally unaffected (Table 6). In line 
with the observations for IL-8 gene expression, abso-
lute IL-8 levels were not significantly affected (Figure 
4b, Supplementary Table S5).
DISCUSSION
Modulation of the commensal oral microbiota, by for 
instance prebiotic substrates, has gained a lot of 
interest as a promising preventive or therapeutic 
approach in oral healthcare. In this study, four new 
potential prebiotic substrates (NADG, α-D-lactose, 
D-(+)-trehalose and D-(+)-raffinose) were shown to 
modulate in vitro oral multi-species biofilms in such 
a way that they became more host-compatible. 
Repeated rinsing of established biofilms with the sub-
strates resulted in a shift towards a more health- 
associated microbiological composition, an altered 
metabolic activity, often downregulated the expres-
sion of a selection of virulence genes and decreased 
the inflammatory effect on human oral keratinocytes.
Figure 4. Effects of repeated rinsing with potential prebiotic substrates on multi-species biofilm inflammatory potential.
IL-8 levels detected in the supernatants of human oral keratinocytes (HOK-18A) cultures exposed to substrate-treated multi-species biofilms are 
shown as mean ± SD (n = 3) values (pg/mL). Substrates were dissolved in PBS at a concentration of 1 M (panel a) or 1%(w/v) (panel b) 
(corresponding molar concentrations: 45 mM (NADG), 29 mM (α-D-lactose), 17 mM (D-(+)-raffinose) and 26 mM (D-(+)-trehalose)). Statistically 
significantly different values when compared to the control (PBS) are marked with ‘*’ (P < 0.05, ANOVA + Dunnett’s correction for simultaneous 
hypothesis testing). IL-8: interleukin-8; NADG: N-acetyl-D-glucosamine.
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The higher substrate concentration (1 M) tested had 
pronounced effects on all four biofilm aspects, 
whereas the lower concentration (1%(w/v)) had 
a pronounced modulating effect on virulence gene 
expression and a limited effect on inflammatory 
potential. As far as we know, this study is the first 
one to simultaneously investigate the effects of poten-
tial prebiotic substrates on composition, metabolic 
activity, virulence gene expression and inflammatory 
potential of an in vitro, complex 14-species oral 
biofilm.
An important overall observation of this study was 
the concentration dependence of the effects the sub-
strates had. The rationale for using two different 
concentrations, a high one (1 M) and a lower one 
(1%(w/v)), is that the 1 M concentration allows for 
comparison with a previous in vitro study [26]. In 
that study, in which the prebiotic concept for oral 
healthcare was expanded to more complex multi- 
species biofilms, the beneficial effects of the potential 
prebiotic substrates were most pronounced for con-
centrations corresponding to the 1 M concentration 
of the current study. Although such high concentra-
tions can be justified when working at an in vitro 
level to proof certain concepts, they might be more 
difficult to apply in a real-life situation. Therefore, 
a lower concentration was evaluated as well. 
A concentration of 1%(w/v) is a realistic concentration 
for formulating compounds in commercially available 
mouthwashes or toothpastes.
Initiation and progression of oral diseases are char-
acterized by a dysbiosis of the oral microbiota, in which 
there is an increase in pathobiont species and a decrease 
in commensal/beneficial species abundance and activity 
[8,10,11,37–39]. Avoiding and/or counteracting such 
microbiological changes is thus of utmost importance 
for maintaining and/or restoring a health-associated 
homeostatic microbiological composition. Rinsing the 
biofilms with the substrates at 1 M caused pronounced 
increases in the proportions and amounts of beneficial/ 
commensal species and decreases in those of the period-
ontal pathogens. These alterations resulted in 
a theoretically more health-associated biofilm composi-
tion from a periodontitis point of view [1,3,11,40–42]. 
On the other hand, changes were often less favourable 
from a caries point of view, as reflected by most of the 
changes in numbers of S. mutans and S. sobrinus, two of 
the primary organisms associated with dental caries 
[43–46]. However, for NADG, a decrease in 
S. sobrinus was observed, which could originate in 
a competitive advantage for S. mutans based on differ-
ences in the ability to ferment NADG, as has been 
described previously [47–50]. The overall less favour-
able effects on the cariogenic pathogens could be 
addressed by, for instance, combinations with 
L-arginine, a substrate that has been shown to have 
several beneficial effects from a caries point of view 
[28–30,51,52]. Pronounced changes in multi-species 
oral biofilm composition following rinsing with poten-
tial prebiotic substrates similar to the ones observed in 
the current study were also previously reported by 
Slomka and co-workers [26]. In that study, the most 
promising potential prebiotic substrate tested at 
a concentration of 1 M resulted for instance in a biofilm 
composition consisting of 97% beneficial/commensal 
species and reduced F. nucleatum and P. gingivalis 
numbers with 1.5–2 log(Geq/mL). In contrast with all 
the above, limited to no compositional changes were 
observed for substrates at 1%(w/v). Such different effects 
on microbiological composition for different concen-
trations have been reported previously for other poten-
tial prebiotic substrates both in oral and gastro- 
intestinal research [26,53,54]. In addition, also the rela-
tively limited duration of the treatment might play 
a role.
Microbiological composition and interactions 
might influence metabolic activity and vice versa [-
55–64], which is why also the function, i.e. metabolic 
activity, of the microbiota should be evaluated [27]. 
In this study, changes in levels of organic acids play-
ing key roles in oral bacterial metabolic pathways 
were investigated. This was done to partially cover 
the complexity of our multi-species model, as differ-
ent metabolic profiles can be distinguished based on 
bacterial species and localization in the oral cavity 
[60,64]. Streptococcus and Actinomyces species are 
usually found more supragingivally and have 
a saccharolytic metabolism resulting in the produc-
tion of lactate, formate and acetate [64]. The pro-
duced lactate forms an energy source for Veillonella, 
Actinomyces and Aggregatibacter species 
[55,56,64,65]. Veillonella species metabolize it into 
formate, acetate and propionate [64], whereas 
Actinomyces species metabolize it into acetate [64]. 
Subgingival sites are more dominated by asaccharo-
lytic and/or proteolytic species like Fusobacterium, 
Porphyromonas and Prevotella that metabolize nitro-
genous substrates into small peptides and amino 
acids, which are in turn degraded to propionate, 
butyrate, acetate and formate [60,64]. The amino 
sugar NADG and sugars α-D-lactose, D-(+)- 
trehalose and D-(+)-raffinose are mainly metabolized 
through saccharolytic pathways to provide a carbon 
source and also a nitrogen source in the case of 
NADG [47,66–72]. Biofilm treatment with the sub-
strates at 1 M caused pronounced changes in organic 
acid levels that can often be at least partially 
explained by the observed compositional changes. 
For instance, only NADG rinsing did not increase 
lactate production. NADG rinsing had stimulating 
effects on two streptococcal numbers, but it also 
decreased S. sobrinus numbers and simultaneously 
did not decrease V. parvula numbers, in contrast 
with the three other substrates. On the other hand, 
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Actinomyces spp. were decreased in the substrate- 
treated biofilms, although less pronounced for 
NADG and D-(+)-raffinose than for the two other 
substrates. Altogether, this can explain the observed 
changes in lactate and acetate levels. Similar changes 
have already been described in literature [32,55]. 
Fernandez y Mostajo et al. reported decreased 
Veillonella and Streptococcus species accompanied 
by increased lactate and decreased acetate levels fol-
lowing treatment of in vitro multi-species biofilms 
[55]. Similarly, different magnitudes of decreases in 
formate and propionate levels can be attributed to the 
different magnitudes in decreases in, for instance, 
F. nucleatum, P. gingivalis, P. intermedia, V. parvula 
and Actinomyces spp. Increased propionate levels 
could be due to unaffected numbers of V. parvula 
and different magnitudes of decreases in periodontal 
pathogens. Finally, decreased butyrate levels can be 
attributed to pronounced decreases in anaerobic pro-
teolytic species caused by all substrates. Given the 
extensive metabolic cross-feeding in oral biofilms, it 
is challenging to fully elucidate what the metabolic 
impact of the substrate treatments is. The lack of 
changes observed for substrates at 1%(w/v) was most 
likely due to the absence of compositional changes.
The virulence profiles of our multi-species biofilms 
were evaluated at the expression level of a selection of 
well-known virulence genes from the periodontal 
pathobionts [73–78] incorporated in the biofilms. 
Treatment of the biofilms with the substrates at 
1 M caused pronounced changes in virulence gene 
expression. Expression of nearly all 
A. actinomycetemcomitans and P. gingivalis virulence 
genes was strongly downregulated, which are genes 
encoding proteins involved in a wide range of pathol-
ogy-associated processes such as cell adhesion, inva-
sion and colonization, cytotoxicity, host tissue 
degradation and immune evasion (Supplementary 
Table S4). Remarkable was the upregulated expres-
sion of pgA obtained for all substrates. This gene is 
involved in the synthesis of a linear polymer of 
NADG residues in β(1,6)linkage that is part of an 
extracellular polysaccharide matrix involved in bio-
film formation and colonization [79,80]. 
Upregulation of pgA as part of the extracytoplasmatic 
stress response has been described for other 
Aggregatibacter species [81]. Apart from being 
a widespread structural component of bacterial cell 
walls (peptidoglycan) [47], NADG is also known to 
function as a signalling molecule and to be involved 
in the regulation of virulence gene expression [82,83]. 
However, it is unclear whether the substrates them-
selves directly affect virulence gene expression in the 
biofilms or if the observed changes are the result of 
the complex interplay between other biofilm aspects. 
Noteworthy was the upregulation of F. nucleatum 
virulence gene expression, something which is usually 
seen in dysbiotic biofilms [35,84,85]. However, for 
the NADG treatment the expression of most 
F. nucleatum virulence genes remained unaffected. 
The varying effects of NADG treatment on gene 
expression in the different periodontopathogens cor-
respond with what has been previously described for 
different microbial species [82]. Even though treat-
ment with the substrates at 1%(w/v) did not result in 
significant compositional and metabolic changes, 
virulence gene expression was still affected. This is 
in line with what has been described for subinhibitory 
concentrations of some antibiotics and antiseptics, 
which affected bacterial virulence gene expression in 
certain species at concentrations too low to influence 
bacterial growth/survival [86–88]. Highly remarkable 
was that gene expression patterns were sometimes 
completely opposed to those observed for treatment 
with the substrates at 1 M. However, the explanation 
for this remains currently unclear. To conclude, 
a wide range of studies on dysbiotic oral biofilms 
reported increased expression of virulence genes 
involved in the same or similar processes and func-
tions as those evaluated in this study [35,84,85,89–-
91]. In the current study, effects on virulence gene 
expression were found to be highly dependent on the 
substrate, substrate concentration and the bacterial 
species and gene under consideration. However, the 
initiation and progression of oral pathologies are 
a consequence of the collective composition, function 
and virulence of the entire, synergistic polymicrobial 
community [11,92–94]. Therefore, it is important to 
look at the bigger picture. When considering the 
overall effect, often a favourable decreased virulence 
gene expression was observed.
Inflammation is considered an ecological driver of 
dysbiosis, with the initiation and progression of per-
iodontal diseases seeming to be the product of 
a reciprocal, self-sustaining feedforward loop between 
dysbiosis and inflammation [95]. Therefore, it was 
evaluated whether the substrate-treated biofilms 
showed an altered inflammatory potential. The eval-
uated genes encode inflammatory mediators that are 
all well known for their involvement in periodontitis 
[36,96–100]. Gene expression data revealed that the 
effects on the inflammatory potential of the biofilms 
were highly dependent on the substrate and substrate 
concentration. For substrates at 1 M, especially IL-8 
gene expression levels were strongly downregulated, 
which was also reflected in the strongly decreased 
absolute IL-8 levels. In periodontitis, oral keratino-
cytes produce IL-8 in the presence of pro- 
inflammatory cytokines, such as IL-1β and TNF-α, 
which in turn acts as a potent activator and attractant 
of neutrophils [98,100,101]. Elevated IL-8 levels have 
been described in patients with severe periodontitis 
and are also considered to be important indicators for 
the onset of oral diseases [100,102,103]. Our data thus 
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point towards a theoretically more periodontal 
health-associated inflammatory status. The effects 
on inflammatory response can also be linked to the 
observed changes in biofilm composition, metabolic 
activity and virulence gene expression. It is well 
known that periodontal pathogens and dysbiotic bio-
films can elicit strong epithelial inflammatory 
responses [12,35,36,96–100]. The shifts in biofilm 
composition obtained for substrates at 1 M probably 
contributed to the lowered inflammatory response. 
This is also related to the observed changes in meta-
bolic activity, as periodontal inflammation is thus 
associated with a dysbiotic community predomi-
nantly consisting of proteolytic and asaccharolytic 
species [12,95]. Metabolic changes associated with 
an improvement of periodontal disease status are, 
for instance, increases in lactate levels and decreases 
in propionate, butyrate and acetate levels [55]. 
Especially decreased butyrate levels can be considered 
favourable, as butyrate production by periodontal 
pathogens is highly associated with the inflammation 
that occurs during periodontal disease [104–106]. All 
substrates tested in this study caused at least one, and 
often three or four, of such changes at 
a concentration of 1 M. Furthermore, many of the 
genes for which expression was downregulated 
encode virulence factors involved in cell adhesion 
and invasion, cytotoxicity and other processes that 
play crucial roles in the onset and progression of 
inflammation. Even though the treatment of the bio-
films with substrates at 1%(w/v) only had a limited 
effect on their inflammatory potential, they could 
affect the inflammatory response more indirectly, 
like through the observed downregulated expression 
of such virulence genes.
When evaluating the effects of potential therapies at 
an in vitro level, one needs to be aware of certain 
limitations and differences when compared to the 
in vivo situation. Complex microbial communities are 
characterized by inter- and intra-species interactions 
and metabolic cross-feeding, which has to be taken 
into account when evaluating potential prebiotic effects 
[58,107]. Other factors of importance are, for instance, 
the limited application time in the mouth and wash-out 
and dilution effects of the salivary and crevicular fluid 
flow [108]. Given all of this, the experimental set-up 
and approach used in this study tried to consider 
several of these factors. Therefore, it was decided to 
immediately look at the effects of the substrates on the 
level of complex, multi-species biofilms grown on ver-
tical hydroxyapatite disks, mimicking the tooth surface 
and orientation. The applied rinsing protocol simu-
lated regular, repeated exposure to the substrates, as 
would also be the case in real-life when brushing the 
teeth or using mouthwashes. In line with that, the pH 
of the substrate solutions was adjusted to 5.7, a pH also 
found in commercially available mouthwashes. To 
conclude, future research should focus on certain 
aspects that were not addressed in the current study. 
Such aspects include, for instance, the exact mode of 
action of the substrates, the inclusion of other types of 
relevant immune cells, determination of actual protein 
levels of the evaluated virulence factors and looking 
into possible combinations of substrates to reduce the 
concentrations needed to achieve certain effects. 
Regarding the latter, an additional study will be per-
formed to investigate a substrate concentration range 
from 1%(w/v) to 5%(w/v) and to look into the combina-
tory effects of different substrates at physiologically 
relevant concentrations. Eventually, the substrates will 
need to be tested under in vivo conditions to fully 
determine their microbiological and clinical potential.
Overall, this study identified four new potential 
prebiotic substrates, NADG, α-D-lactose, D-(+)- 
trehalose and D-(+)-raffinose, that exhibit different 
modulatory effects at two different concentrations, 
that cause in vitro multi-species oral biofilms to 
become more host-compatible. The observed compo-
sitional, metabolic and inflammatory changes were 
usually only observed for the highest concentration 
(1 M) tested, whereas changes in virulence gene 
expression were found to be highly dependent on 
substrate type and concentration, bacterial species 
and gene under consideration.
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